Taysha Gene Therapies shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $969k | 296k | 3.27 |
| 2025-03-31 | $1.4M | 1.0M | 1.39 |
| 2024-12-31 | $4.6M | 2.6M | 1.73 |
| 2024-09-30 | $6.0M | 3.0M | 2.01 |
| 2024-06-30 | $6.6M | 3.0M | 2.24 |
| 2024-03-31 | $269k | 94k | 2.87 |
| 2023-12-31 | $65k | 37k | 1.77 |
| 2023-09-30 | $433 | 137 | 3.16 |
| 2023-06-30 | $1.2k | 1.8k | 0.66 |
| 2023-03-31 | $1.0k | 1.8k | 0.56 |
| 2022-12-31 | $4.0k | 1.8k | 2.24 |
| 2022-06-30 | $1.0M | 279k | 3.72 |
| 2022-03-31 | $2.9M | 440k | 6.58 |
| 2021-12-31 | $2.8M | 238k | 11.65 |
| 2021-03-31 | $532k | 26k | 20.30 |
| 2020-12-31 | $457k | 24k | 19.23 |